View in EDS

GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.

Saved in:
Bibliographic Details
Title: GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.
Authors: Labrada M; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba., Dorvignit D; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba., Hevia G; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba., Rodríguez-Zhurbenko N; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba., Hernández AM; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba., Vázquez AM; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba., Fernández LE; Innovation Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba. Electronic address: luis@cim.sld.cu.
Source: Seminars in oncology [Semin Oncol] 2018 Jan; Vol. 45 (1-2), pp. 41-51. Date of Electronic Publication: 2018 May 07.
Publication Type: Journal Article; Review
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8708 (Electronic) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30318083
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Labrada+M%22">Labrada M</searchLink>; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba.<br /><searchLink fieldCode="AU" term="%22Dorvignit+D%22">Dorvignit D</searchLink>; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba.<br /><searchLink fieldCode="AU" term="%22Hevia+G%22">Hevia G</searchLink>; Immunobiology Division, Molecular Immunology Institute, Center of Molecular Immunology (CIM), Playa, Havana, Cuba.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Zhurbenko+N%22">Rodríguez-Zhurbenko N</searchLink>; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba.<br /><searchLink fieldCode="AU" term="%22Hernández+AM%22">Hernández AM</searchLink>; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba.<br /><searchLink fieldCode="AU" term="%22Vázquez+AM%22">Vázquez AM</searchLink>; Tumor Biology Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba.<br /><searchLink fieldCode="AU" term="%22Fernández+LE%22">Fernández LE</searchLink>; Innovation Division, Molecular Immunology Institute, CIM, Playa, Havana, Cuba. Electronic address: luis@cim.sld.cu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220420432%22">Seminars in oncology</searchLink> [Semin Oncol] 2018 Jan; Vol. 45 (1-2), pp. 41-51. <i>Date of Electronic Publication: </i>2018 May 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders%22">W.B. Saunders </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0420432 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-8708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200937754%22">00937754 </searchLink><i>NLM ISO Abbreviation: </i>Semin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30318083
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1053/j.seminoncol.2018.04.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 41
    Titles:
      – TitleFull: GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Labrada M
      – PersonEntity:
          Name:
            NameFull: Dorvignit D
      – PersonEntity:
          Name:
            NameFull: Hevia G
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Zhurbenko N
      – PersonEntity:
          Name:
            NameFull: Hernández AM
      – PersonEntity:
          Name:
            NameFull: Vázquez AM
      – PersonEntity:
          Name:
            NameFull: Fernández LE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2018 Jan
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1532-8708
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 1-2
          Titles:
            – TitleFull: Seminars in oncology
              Type: main
ResultId 1